Glucagonomas, VIPomas and somatostatinomas

Allison, 1977, Treatment of carcinoid liver metastases by hepatic-artery embolisation, Lancet, ii, 1323, 10.1016/S0140-6736(77)90369-5 Bloom, 1978, Somatostatin and gut, Gastroenterology., 75, 145, 10.1016/0016-5085(78)93782-4 Bloom, 1978, The glucagonoma syndrome, 183, 10.1007/978-1-4684-7248-6_23 Bloom, 1978, Multiple hormone forms in PPomas, VIPomas and glucagonomas, Scandinavian Journal of Gastroenterology, 13, 24 Bloom, 1973, Vasoactive intestinal peptide and watery diarrhoea syndrome, Lancet, ii, 14, 10.1016/S0140-6736(73)91947-8 Bloom, 1978, Somatostatin content of pancreatic endocrine tumours, 27, 1235 Bloom, 1979, Pancreatic apudomas, World Journal of Surgery., 3, 587, 10.1007/BF01654765 Gagel, 1976, Streptozotocin-treated Verner-Morrison syndrome. Plasma vasoactive intestinal peptide and tumour responses, Archives of International Medicine, 136, 1429, 10.1001/archinte.1976.03630120075019 Ganda, 1977, Somatostatinoma — a somatostatin-containing tumour of the endocrine pancreas, New England Journal of Medicine, 297, 1352 Greenberg, 1978, Inhibition of pancreas and gall bladder by pancreatic polypeptide, Lancet, ii, 1280, 10.1016/S0140-6736(78)92042-1 Heitz, 1976, Identification of the D1-cell as the source of human pancreatic polypeptide (HPP), Gut., 17, 755, 10.1136/gut.17.10.755 Ingemansson, 1976, Selective catheterization of the pancreatic vein for radioimmunoassay in glucagon-secreting carcinoma of the pancreas, Radiology., 119, 555, 10.1148/119.3.555 Ringham, 1978, VIPoma: localisation by percutaneous transhepatic portal venous sampling, British Medical Journal., ii, 1682, 10.1136/bmj.2.6153.1682-a Larsson, 1977, Pancreatic somatostatinoma. Clinical features and physiological implications, Lancet, i, 666, 10.1016/S0140-6736(77)92113-4 Lin, 1972, Spectrum of gastrointestinal actions on a new bovine pancreatic polypeptide (BPP), Gastroenterology., 62, 852 Long, 1979, Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue, Lancet, ii, 764, 10.1016/S0140-6736(79)92115-9 Long, 1979, Clinico-pathological study of pancreatic and neural VIPomas, Gut, A934 Mallinson, 1978, The hyperglycemic, cutaneous syndrome: pancreatic glucagonoma, 171 Mallinson, 1974, A glucagonoma syndrome, Lancet, ii, 1, 10.1016/S0140-6736(74)91343-9 Mallinson, 1977, Metabolic and clinical responses in patients with pancreatic glucagonomas, Irish Journal of Medical Science, 146, 37 Modlin, 1978, Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischemia, Experientia., 34, 535, 10.1007/BF01935976 Modlin, 1978, Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhoea syndrome, Gastroenterology., 75, 1051, 10.1016/0016-5085(78)90074-4 Polak, 1976, Pancreatic polypeptide in insulinomas, gastrinomas. VIPomas and glucagonomas, Lancet., i, 328, 10.1016/S0140-6736(76)90084-2